FDA Takes Action Aimed at Helping to Ensure the Safety and Effectiveness of Laboratory Developed Tests
Today, the U.S. Food and Drug Administration took action aimed at helping to ensure the safety and effectiveness of laboratory developed tests
Today, the U.S. Food and Drug Administration took action aimed at helping to ensure the safety and effectiveness of laboratory developed tests
Ashish Kamat converses with Akshay Sood about the challenging diagnosis and management of non-metastatic plasmacytoid bladder cancer. Dr. Sood elaborates on his comprehensive study published…
The European Medicines Agency (EMA) on Friday recommended scrapping approval for a drug used to prolong gestation, citing a “possible but unconfirmed” risk of cancer.
Mark Tyson presents results from the BOND-003 study, evaluating the efficacy of cretostimogene grenadenorepvec monotherapy in treating BCG-unresponsive non-muscle-invasive bladder cancer. Cretostimogene, an oncolytic adenovirus,…
Data from wearables can be powerful but they’re not useful to doctors yet, experts said at the #STATBreakthrough Summit in San Francisco.
If spiders use their webs like a large external eardrum, researchers reasoned, perhaps spider silk could be the basis for a powerful listening device.
Findings demonstrated a slower decline in kidney function for patients treated with sparsentan or irbesartan compared with standard of care in both real-world and clinical…
At the 2024 UCSF-UCLA PSMA Conference, Matthew Rettig discusses the critical advancements and challenges in treating metastatic castration-resistant prostate cancer (mCRPC), highlighting the shift towards…
Prostate Cancer, PRAISE-U, prostate cancer awareness, prostate cancer screening, prostate cancer early detection, Promoting Risk-Based Screening for Early Detection of Prostate Cancer in Europe.
A review of a limited number of cases of unresponsive patients with severe traumatic brain injuries raised questions about a custom of making a decision…